Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04701307 |
|---|---|
| Brief Title: | Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas |
| First Submitted : | January 6, 2021 |
| First Submitted that Met QC Criteria : | January 6, 2021 |
| First Posted : | January 8, 2021 |
| Last Update Submitted that Met QC Criteria : | September 30, 2021 |
| Last Update Posted : | October 6, 2021 |